Role of Amylin in Type 1 and Type 2 Diabetes

6. Glycemic Targets

(2014)   DIABETES CARE

Minimal Reduction in Insulin Dosage with Pramlintide Therapy when Pretreatment Near-Normal Glycemia is Established and Square-Wave Meal Bolus is Used

(2013) Allen King   Endocrine Practice

Amylin Uncovered: A Review on the Polypeptide Responsible for Type II Diabetes

(2013) Karen Pillay et al.   Biomed Research International

Use of continuous glucose monitoring to introduce adjunctive pramlintide therapy in a patient with type 1 diabetes: A case study

(2011) Tomas C. Walker   Journal of the American Academy of Nurse Practitioners

Islet Amyloid Polypeptide, Islet Amyloid, and Diabetes Mellitus

(2011) Per Westermark et al.   PHYSIOLOGICAL REVIEWS

Central amylin acts as an adiposity signal to control body weight and energy expenditure

(2010) Peter Y. Wielinga et al.   PHYSIOLOGY & BEHAVIOR

Sustained Weight Loss Following 12-Month Pramlintide Treatment as an Adjunct to Lifestyle Intervention in Obesity

(2008) S. R. Smith et al.   DIABETES CARE